168 related articles for article (PubMed ID: 37788651)
1. Are we PREPAREd? Concerning the "PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study".
De Carmo Campos A; Cardoso ML; Vicente A
Acta Med Port; 2023 Oct; 36(10):689-690. PubMed ID: 37788651
[No Abstract] [Full Text] [Related]
2. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
3. Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.
van der Wouden CH; Böhringer S; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VHM; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Rial-Sebbag E; Samwald M; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; van Zwet E; Swen JJ; Guchelaar HJ;
Pharmacogenet Genomics; 2020 Aug; 30(6):131-144. PubMed ID: 32317559
[TBL] [Abstract][Full Text] [Related]
4. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE
Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517
[No Abstract] [Full Text] [Related]
5. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics: the path to individualised patient care.
Adelung MR; Fitzsimons VM
Br J Nurs; 2014 Jul 10-23; 23(13):738-9. PubMed ID: 25072336
[No Abstract] [Full Text] [Related]
7. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
8. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
Lazaridis KN
Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
[TBL] [Abstract][Full Text] [Related]
9. Clinical association between pharmacogenomics and adverse drug reactions.
Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics arrives.
Petsko GA
Genome Biol; 2004; 5(6):108. PubMed ID: 15186481
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
13. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
14. Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
Tan-Koi WC; Sung C; Chong YY; Lateef A; Pang SM; Vasudevan A; Aw D; Lui NL; Lee SX; Ren EC; Koay ES; Tay YK; Lim YL; Lee HY; Dong D; Loke C; Tan L; Limenta M; Lee EJ; Toh D; Chan CL
Pharmacogenomics; 2017 Jun; 18(9):881-890. PubMed ID: 28594314
[TBL] [Abstract][Full Text] [Related]
15. Progress and Challenges in Pharmacogenomics.
Van Driest SL; Cascorbi I
Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
[No Abstract] [Full Text] [Related]
16. Pharmacogenomics in Psychiatric Practice.
El-Mallakh RS; Roberts RJ; El-Mallakh PL; Findlay LJ; Reynolds KK
Clin Lab Med; 2016 Sep; 36(3):507-23. PubMed ID: 27514465
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure].
Eliasson E; Wadelius M
Lakartidningen; 2021 May; 118():. PubMed ID: 33973222
[TBL] [Abstract][Full Text] [Related]
18. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
Harrison N
Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
Sleder AT; Kalus J; Lanfear DE
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
[TBL] [Abstract][Full Text] [Related]
20. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
